Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LET gel application techniques in children
NCT04203225Phase 4Completed
- Sponsor
- The Lundquist Institute
- Start
- May 2017
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of lidocaine 10% oropharyngeal spray, epinephrine nasal spray and tetracaine in laceration (2 arms), sponsored by The Lundquist Institute. Primary endpoint: Visual Analog Scale Pain Score. Started May 2017; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayepinephrine nasal spraytetracaine
03
Conditions
laceration
Beyond the preview
Go deeper on NCT04203225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203225.